000 03403nam a22003975i 4500
001 286364
003 MX-SnUAN
005 20160429154456.0
007 cr nn 008mamaa
008 150903s2014 xxk| o |||| 0|eng d
020 _a9781447154754
_99781447154754
024 7 _a10.1007/9781447154754
_2doi
035 _avtls000340107
039 9 _a201509030842
_bVLOAD
_c201404300410
_dVLOAD
_y201402061017
_zstaff
040 _aMX-SnUAN
_bspa
_cMX-SnUAN
_erda
050 4 _aRC681-688.2
100 1 _aDan, Gheorghe-Andrei.
_eeditor.
_9314944
245 1 0 _aAtrial Fibrillation Therapy /
_cedited by Gheorghe-Andrei Dan, Antoni Bayés de Luna, John Camm.
264 1 _aLondon :
_bSpringer London :
_bImprint: Springer,
_c2014.
300 _axiv, 188 páginas 26 ilustraciones, 15 ilustraciones en color.
_brecurso en línea.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
490 0 _aCurrent Cardiovascular Therapy
500 _aSpringer eBooks
505 0 _aEpidemiology, burden and unmet needs in atrial fibrillation -- Inside Molecular Mechanisms and pharmacological Targets of Atrial Fibrillation -- Novel oral anticoagulants for stroke prevention in patients with non-valvular atrial fibrillation -- Upstream therapy in the treatment of atrial fibrillation -- Drug therapy for rhythm and rate control in Atrial Fibrillation -- Changing the paradigm to understand and manage Atrial Fibrillation -- Guidelines and current recommendations in Atrial Fibrillation.
520 _aThis book presents the current evidence and practice in the pharmacological treatment of atrial fibrillation (AF). AF management has changed significantly in recent years as a new era has begun for the prevention of stroke, one of the most devastating complications of AF. Prevention of ischemic stroke in AF patients with oral anticoagulants represents a huge challenge and the enormous amount of research is revealing new treatment opportunities at a dizzying pace. While new classes of antithrombotic drugs for AF treatment are still in their infancy, recent research is revealing how these can be applied with optimal efficacy. Atrial Fibrillation Therapy includes practical information for readers on applying the guidelines developed as a result of the increased pharmacotherapeutic understanding. This book also guides trainees, recertifying physicians, and practicing physicians in internal medicine, cardiology, emergency medicine, and clinical pharmacology to apply the new diagnostic tools for selecting the best treatment options for AF patients. Discusses new diagnostic tools for selecting therapies for AF patients Presents recent research in a highly practical, easy reference style Emphasis on a just-the-facts approach to the treatment options in AF
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
700 1 _aBayés de Luna, Antoni.
_eeditor.
_9314945
700 1 _aCamm, John.
_eeditor.
_9314946
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9781447154747
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-1-4471-5475-4
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c286364
_d286364